Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AngioDynamics, Inc. - Common Stock (NQ: ANGO )

9.120 -0.280 (-2.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AngioDynamics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Is This Under-the-Radar Growth Stock a Buy?
This company is a small player in the steadily growing medtech industry. 
Via The Motley Fool
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization... 
Via Benzinga
AngioDynamics Reports Fiscal 2023 Second Quarter Financial Results; Reaffirms Guidance
From AngioDynamics, Inc.
Via Business Wire
Earnings Preview For AngioDynamics
Via Benzinga
Why AngioDynamics Stock Just Crashed 12%
Is AngioDynamics' earnings miss a buying opportunity? 
Via The Motley Fool
Nasdaq, S&P 500 Futures Edgy Ahead Of Data-Heavy Session — Analyst Says Markets In 'Holding Pattern' In Anticipation Of Q4 Results, CPI Print
U.S. stocks look set to open Thursday’s session on a nervous note, potentially reversing the gains from the previous session. 
Via Benzinga
Earnings Scheduled For January 5, 2023
Companies Reporting Before The Bell • Schnitzer Steel Indus (NASDAQ:SCHN) is expected to report quarterly loss at $0.45 per share on revenue of $602.73 million. 
Via Benzinga
Wall Street Thinks This Obscure Growth Stock Could Soar 92% in 2023
As COVID-19 headwinds fade, AngioDynamics' business could rebound. 
Via The Motley Fool
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics Shares Fall On Lower Than Expected Q1 Earnings, Reaffirms Annual Guidance
Via Benzinga
AngioDynamics: Q1 Earnings Insights
AngioDynamics (NASDAQ:ANGO) reported its Q1 earnings results on Thursday, October 6, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
AngioDynamics to Report Fiscal 2023 Second Quarter Financial Results on January 5, 2023
From AngioDynamics, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's session, 107 stocks hit new 52-week lows. 
Via Benzinga
Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday
Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share. 
Via Benzinga
Credit Suisse, Autodesk And Other Big Losers From Wednesday
U.S. stocks closed higher on Wednesday, with the Nasdaq Composite gaining more than 100 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Why PagSeguro Digital Shares Are Trading Lower By 18%? Here Are 40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) rose 68% to $0.5500 after surging around 87% on Tuesday. Cosmos Holdings recently posted a Q3 loss of $0.08 per share. 
Via Benzinga
AngioDynamics to Present at the Piper Sandler Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics Announces First Patient Enrolled in APEX-AV Study Assessing AlphaVac F1885 PE System in Treatment of Pulmonary Embolism
From AngioDynamics, Inc.
Via Business Wire
Here's Why This Hidden Growth Stock Is a Buy
This medical device company may not be a household name, but it could be an up-and-comer. 
Via The Motley Fool
$20 Million Bet On Rocket Pharmaceuticals? 3 Stocks Insiders Are Buying
Although US crude oil prices traded lower on Wednesday, there were a few notable insider trades. 
Via Benzinga
Constellation Brands To Rally 21%? Plus Wells Fargo Predicts $225 For Visa
UBS raised Constellation Brands, Inc. (NYSE: STZ) price target from $270 to $281. Constellation shares fell 0.1% to $232.38 in pre-market trading. 
Via Benzinga
Dow Dips Over 300 Points; Provention Bio Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 300 points on Thursday. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers 
Via Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday. 
Via Benzinga
Stocks Edge Lower As Bond Yields Rise
Wall Street is taking a step back, as sentiment wanes and bond yields rise. 
Via Talk Markets
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of... 
Via Benzinga
Nasdaq Edges Higher; AngioDynamics Shares Plummet
U.S. stocks pared losses midway through trading, with the Nasdaq Composite turning higher on Thursday. 
Via Benzinga
AngioDynamics, Resources Connection And Some Other Big Stocks Moving Lower On Thursday
U.S. stocks traded mixed, with the Dow Jones dropping more than 85 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
AngioDynamics Reports Fiscal 2023 First Quarter Financial Results; Reaffirms Guidance
From AngioDynamics, Inc.
Via Business Wire
Earnings Scheduled For October 6, 2022
Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.52 per share on revenue of $2.85 billion. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.